AU469986B2 - Sulfobenzylpenicillin salts - Google Patents

Sulfobenzylpenicillin salts

Info

Publication number: AU469986B2
Authority: AU; Australia
Prior art keywords: sulfobenzylpenicillin; salts; sulfobenzylpenicillin salts
Prior art date: 1972-07-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

AU57600/73A

Other languages

English (en)

Other versions

AU5760073A (en

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Takeda Pharmaceutical Co Ltd

Original Assignee

Takeda Chemical Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1972-07-01

Filing date

1973-07-02

Publication date

1976-02-26

1973-07-02 Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd

1975-01-09 Publication of AU5760073A publication Critical patent/AU5760073A/en

1976-02-26 Application granted granted Critical

1976-02-26 Publication of AU469986B2 publication Critical patent/AU469986B2/en

Status Expired legal-status Critical Current

Links

FWRNIJIOFYDBES-HCIBPFAFSA-L sulbenicillin disodium Chemical class [Na+].[Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)C(S([O-])(=O)=O)C1=CC=CC=C1 FWRNIJIOFYDBES-HCIBPFAFSA-L 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AU57600/73A 1972-07-01 1973-07-02 Sulfobenzylpenicillin salts Expired AU469986B2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP6630172A JPS5512435B2 (2)	1972-07-01	1972-07-01
JPJP66301/72		1972-07-01

Publications (2)

Publication Number	Publication Date
AU5760073A AU5760073A (en)	1975-01-09
AU469986B2 true AU469986B2 (en)	1976-02-26

Family

ID=13311838

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU57600/73A Expired AU469986B2 (en)	1972-07-01	1973-07-02	Sulfobenzylpenicillin salts

Country Status (15)

Country	Link
US (1)	US3925357A (2)
JP (1)	JPS5512435B2 (2)
AT (1)	AT325206B (2)
AU (1)	AU469986B2 (2)
BE (1)	BE801588A (2)
CA (1)	CA996548A (2)
CH (1)	CH573435A5 (2)
CS (1)	CS168036B2 (2)
DE (1)	DE2332840A1 (2)
FR (1)	FR2190414B1 (2)
GB (1)	GB1386566A (2)
HU (1)	HU166029B (2)
NL (1)	NL7308048A (2)
PL (1)	PL92969B1 (2)
SE (1)	SE402916B (2)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5522148U (2) *	1978-07-29	1980-02-13
KR100926247B1 (ko) *	2001-02-24	2009-11-12	베링거 잉겔하임 파르마 게엠베하 운트 코 카게	크산틴 유도체를 포함하는 약제학적 조성물 및 이의제조방법
US20030171424A1 (en) *	2002-03-07	2003-09-11	Lin Ai J.	Intravenous formulation of artelinic acid for treatment of severe and complicated malaria
US7407955B2 (en)	2002-08-21	2008-08-05	Boehringer Ingelheim Pharma Gmbh & Co., Kg	8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) *	2004-02-18	2009-03-10	Boehringer Ingelheim International Gmbh	8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de)	2004-11-05	2006-05-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) *	2005-07-30	2007-02-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
KR101452915B1 (ko) *	2006-05-04	2014-10-21	베링거 인겔하임 인터내셔날 게엠베하	다형태
PE20110235A1 (es)	2006-05-04	2011-04-14	Boehringer Ingelheim Int	Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
EP1852108A1 (en)	2006-05-04	2007-11-07	Boehringer Ingelheim Pharma GmbH & Co.KG	DPP IV inhibitor formulations
BRPI0815405A2 (pt) *	2007-08-17	2015-02-03	Boehringer Ingelheim Int	Compostos derivados de purina, processo para a preparação de uma composição farmacêutica e uso dos mesmos
PE20091730A1 (es)	2008-04-03	2009-12-10	Boehringer Ingelheim Int	Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) *	2008-06-03	2010-02-23	Boehringer Ingelheim Int	Tratamiento de nafld
UY32030A (es)	2008-08-06	2010-03-26	Boehringer Ingelheim Int	"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
KR20190016601A (ko)	2008-08-06	2019-02-18	베링거 인겔하임 인터내셔날 게엠베하	메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UA119131C2 (uk) *	2008-08-15	2019-05-10	Бьорінгер Інгельхайм Інтернаціональ Гмбх	Похідні пурину для застосування при лікуванні пов'язаних із fab захворювань
CA2736421A1 (en)	2008-09-10	2010-03-18	Boehringer Ingelheim International Gmbh	Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en)	2018-11-20	2020-05-21	Boehringer Ingelheim International Gmbh	Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
JP2012512848A (ja)	2008-12-23	2012-06-07	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	有機化合物の塩の形態
TW201036975A (en)	2009-01-07	2010-10-16	Boehringer Ingelheim Int	Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
KR20240090632A (ko)	2009-11-27	2024-06-21	베링거 인겔하임 인터내셔날 게엠베하	리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
CA3070513C (en)	2010-05-05	2023-01-03	Boehringer Ingelheim International Gmbh	A dpp-4 inhibitor for use in treatment of skin-alterations or necrosis
KR20130093012A (ko)	2010-06-24	2013-08-21	베링거 인겔하임 인터내셔날 게엠베하	당뇨병 요법
AR083878A1 (es)	2010-11-15	2013-03-27	Boehringer Ingelheim Int	Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
DK2731947T3 (en)	2011-07-15	2019-04-23	Boehringer Ingelheim Int	SUBSTITUTED DIMERIC QUINAZOLINE DERIVATIVE, PREPARATION AND USE thereof IN PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF TYPE I AND TYPE II DIABETES
US9555001B2 (en)	2012-03-07	2017-01-31	Boehringer Ingelheim International Gmbh	Pharmaceutical composition and uses thereof
WO2013171167A1 (en)	2012-05-14	2013-11-21	Boehringer Ingelheim International Gmbh	A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
WO2013171166A1 (en)	2012-05-14	2013-11-21	Boehringer Ingelheim International Gmbh	A xanthine derivative as dpp-4 inhibitor for use in the treatment of sirs and/or sepsis
WO2013174767A1 (en)	2012-05-24	2013-11-28	Boehringer Ingelheim International Gmbh	A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
EP3110449B1 (en)	2014-02-28	2023-06-28	Boehringer Ingelheim International GmbH	Medical use of a dpp-4 inhibitor
EP4233840A3 (en)	2016-06-10	2023-10-18	Boehringer Ingelheim International GmbH	Combinations of linagliptin and metformin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1026793A (fr) *	1949-08-02	1953-05-04	American Cyanamid Co	Procédé de préparation de sels de pénicilline
NL6803062A (2) *	1967-03-10	1968-09-11
US3557094A (en) *	1968-01-05	1971-01-19	Pfizer & Co C	Substituted alkyl esters of alpha-carboxy aryl penicillins
AT290728B (de) *	1968-09-28	1971-05-15	Takeda Chemical Industries Ltd	Verfahren zur herstellung neuer penicilline

1972
- 1972-07-01 JP JP6630172A patent/JPS5512435B2/ja not_active Expired
1973
- 1973-06-01 HU HUTA1257A patent/HU166029B/hu unknown
- 1973-06-07 FR FR7320833A patent/FR2190414B1/fr not_active Expired
- 1973-06-08 NL NL7308048A patent/NL7308048A/xx not_active Application Discontinuation
- 1973-06-19 US US371528A patent/US3925357A/en not_active Expired - Lifetime
- 1973-06-25 CS CS4540A patent/CS168036B2/cs unknown
- 1973-06-28 SE SE7309138A patent/SE402916B/xx unknown
- 1973-06-28 BE BE132836A patent/BE801588A/xx unknown
- 1973-06-28 DE DE2332840A patent/DE2332840A1/de active Pending
- 1973-06-29 CA CA175,329A patent/CA996548A/en not_active Expired
- 1973-06-29 CH CH955873A patent/CH573435A5/xx not_active IP Right Cessation
- 1973-06-29 AT AT576473A patent/AT325206B/de not_active IP Right Cessation
- 1973-07-02 GB GB3147473A patent/GB1386566A/en not_active Expired
- 1973-07-02 PL PL1973163783A patent/PL92969B1/pl unknown
- 1973-07-02 AU AU57600/73A patent/AU469986B2/en not_active Expired

Also Published As

Publication number	Publication date
CS168036B2 (2)	1976-05-28
FR2190414A1 (2)	1974-02-01
PL92969B1 (2)	1977-04-30
NL7308048A (2)	1974-01-03
CH573435A5 (2)	1976-03-15
JPS4925121A (2)	1974-03-06
HU166029B (2)	1974-12-28
SE402916B (sv)	1978-07-24
CA996548A (en)	1976-09-07
AT325206B (de)	1975-10-10
GB1386566A (en)	1975-03-12
FR2190414B1 (2)	1976-07-02
DE2332840A1 (de)	1974-01-17
US3925357A (en)	1975-12-09
BE801588A (fr)	1973-12-28
JPS5512435B2 (2)	1980-04-02
AU5760073A (en)	1975-01-09

Publication	Publication Date	Title
AU469986B2 (en)	1976-02-26	Sulfobenzylpenicillin salts
AU462348B2 (en)	1975-06-19	Saf-t-jet
AU454372B2 (en)	1974-10-31	Childsafe actuator-overcap
AU470375B2 (en)	1976-03-11	Substituted w-pentanorprostaglandins
AU5996573A (en)	1975-03-06	Pyridinium salts
CA980352A (en)	1975-12-23	Substituted aminohalopyridines
CA950831A (en)	1974-07-09	Biocidal salts
CA995666A (en)	1976-08-24	1-amino-pyridinium salts
CA1020586A (en)	1977-11-08	Bisthioethers
AU5128473A (en)	1974-07-25	Napnthopyrans
CA1005054A (en)	1977-02-08	Dibenzazecine
AU470359B2 (en)	1975-05-22	Sulphamoylphenyl-imidazolidinones
CA991638A (en)	1976-06-22	Substituted 3-cyanobenzenesulfonamides
AU468159B2 (en)	1976-01-08	5-aroyl-furans
CA1010049A (en)	1977-05-10	N-acyl-o-hydrocarbylphosphoroamidothioate salts
AU472956B2 (en)	1976-06-10	Substituted benzodioxoles
CA995680A (en)	1976-08-24	Substituted 2-benzoyloxazolidines
AU473297B2 (en)	1976-06-17	Indolylimidoylheterocyclics
AU467526B2 (en)	1975-12-04	Pyronorifamycins
AU468236B2 (en)	1976-01-08	2-acyl-5-nitrothiazoles
AU5111173A (en)	1974-07-18	15-oxasteroids
CA913109A (en)	1972-10-24	Thienyliodonium salts
CA893696A (en)	1972-02-22	Amcyclodin salts
CA907019A (en)	1972-08-08	N-tritylimidazolium salts
AU491554B1 (en)	1975-03-06	Pyridinium salts